Dan Lewallen brings an extensive background in organic chemistry to every patent in which he is involved. Dan prepares and prosecutes patent applications for pharma companies, material science companies, and universities. In doing so, he manages international patent portfolios for early-stage startups to publicly traded companies.
In addition to patent prosecution, Dan advises on and assists clients with a wide array of patent issues such as due diligence reviews and patentability and freedom-to-operate opinions.
Meticulous attention to detail and the ability to explain complex information in a way that nonprofessionals can understand are at the center of Dan’s core competencies. Analytical by nature, Dan is able to translate complicated science into patent applications that are clear and distinguishable.
Prior to his legal career, Dan worked as a research associate with the Indiana University School of Medicine's Department of Biochemistry and Molecular Biology and was a postdoctoral fellow with The Scripps Research Institute. In these positions, Dan focused on developing chemical probes and inhibitors for protein tyrosine phosphatases, protein arginine deiminases and AMPylators.
HonorsThe Best Lawyers in America, Ones to Watch, 2024